Information Provided By: 
Fly News Breaks for August 7, 2019
AXGN
Aug 7, 2019 | 07:02 EDT
Cantor Fitzgerald analyst Craig Bijou lowered his price target for AxoGen to $21 from $30 after the company reduced its 2019 sales due to delayed productivity growth. While the analyst remains concerned about the trend in top-line growth and the different salesforce issues over the last year, he thinks the revised guidance is achievable. Amid the expected selloff today, Bijou sees a favorable risk/reward on the shares and keeps an Overweight rating on AxoGen.
News For AXGN From the Last 2 Days
There are no results for your query AXGN
